Abstract
INTRODUCTION:Patients with immunocompromised or weakened immune system can develop a disabling and even life-threatening neurological disorder such as progressive multifocal leukoencephalopathy (PML) caused by John Cunningham (JC) virus.
CASE PRESENTATION:We present the case of a 26-year-old man with a recent diagnosis of human immunodeficiency virus (HIV) infection who presented constitutional symptoms, progressive neurological deficit due to left spastic hemiparesis with decreased visual acuity and behavioral changes. The brain Magnetic Resonance Imaging (MRI) showed diffuse subcortical involvement of the white matter including the U-fibers, which, correlated with a detection of JC virus DNA by polymerase chain reaction (PCR) cerebrospinal fluid, confirmed the diagnosis of PML.
DISCUSSION:PML can range from subtle cognitive impairment imperceptible to the clinician to sensory-motor deficits and visual disturbances that can be corroborated in MRI by identifying the typical lesions in the white matter or by detecting the virus by PCR in cerebrospinal fluid. The specific management of the cause that triggered the immunosuppression continues to be the mainstay of treatment.
CONCLUSION:At the minimum diagnostic suspicion in patients with risk factors and clinical manifestations consistent with the disease should proceed to confirm the diagnosis and promptly immune reconstitution.
References
Cortese I, Reich DS, Nath A. Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease. Nat Rev Neurol. 2021;17, 37-51.
Zhai S, Brew BJ. Progressive multifocal leukoencephalopathy. Handb Clin Neurol. 2018;152:123-37.
Kartau M, Sipilà JO, Auvinen E, Palomãki M, Verkkoniemi-Ahola A. Progressive multifocal leukoencephalopathy: current insights. Degener Neurol Neuromuscul Dis. 2019;9:109-21.
Harypursat V, Zhou Y, Tang S, Chen Y JC Polyomavirus, progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome: a review AIDS Res Ther 2020;17:37.
d'Arminio Monforte A, Cinque P, Mocroft A, Goebel FD, Antunes F, Katlama C, et al; EuroSIDA Study Group. Changing incidence of central nervous system diseases in the EuroSIDA cohort. Ann Neurol. 2004;55(3):320-8.
Daniel DC, Kinoshita Y, Khan MA, Del Valle L, Khalili K, Rappaport J, Johnson EM. Internalization of exogenous human immunodeficiency virus-1 protein, Tat, by KG-1 oligodendroglioma cells followed by stimulation of DNA replication initiated at the JC virus origin. DNA Cell Biol. 2004;23(12):858-67.
Moulignier A, Lecler A. Complications neurologiques de l'infection par le virus JC : revue générale [Neurological complications of JC virus infection: A review]. Rev Med Interne. 2021;42(3):177-85.
Sakai M, Higashi M, Fujiwara T, Uehira T, Shirasaka T, Nakanishi K, et al. MRI imaging features of HIV-related central nervous system diseases: diagnosis by pattern recognition in daily practice. Jpn J Radiol. 2021;39(11):1023-38.
Abrão CO, Silva LRMD, Souza LCS, Bisso NM, Turchi MD, Guilarde AO. AIDS-related progressive multifocal leukoencephalopathy. Rev Soc Bras Med Trop. 2020;54:e02522020.
Berger JR, Aksamit AJ, Clifford DB, Davis L, Koralnik IJ, Sejvar JJ, et al. PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology. 2013;80(15):1430-8.
Del Valle L, Piña-Oviedo S. Human polyomavirus JCPyV and Its role in progressive multifocal leukoencephalopathy and oncogenesis. Front Oncol. 2019;9:711.
Summers NA, Kelley CF, Armstrong W, Marconi VC, Nguyen ML. Not a disease of the past: a case series of progressive multifocal leukoencephalopathy in the established antiretroviral era. AIDS Res Hum Retroviruses. 2019;35(6):544-52.
Clifford DB. Hope for progressive multifocal leukoencephalopathy. Lancet Neurol. 2021;20(8):589-91.
Casado JL, Corral I, García J, Martinez-San Millán J, Navas E, Moreno A, Moreno S. Continued declining incidence and improved survival of progressive multifocal leukoencepha-lopathy in HIV/AIDS patients in the current era. Eur J Clin Microbiol Infect Dis. 2014;33(2):179-87.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.